Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Salarius Pharmaceuticals, Inc. (SLRX) had Weighted-Average Shares Outstanding (Diluted) of 0.06M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-5.58M |
|
-- |
|
-- |
|
$5.73M |
|
$-5.73M |
|
$0.16M |
|
$-5.58M |
|
$-5.58M |
|
$-5.58M |
|
$-5.58M |
|
$-5.58M |
|
$-5.58M |
|
$-5.73M |
|
$-5.73M |
|
0.06M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
0.06M |
$-86.81 |
|
$-86.81 |
|
| Balance Sheet Financials | |
$2.99M |
|
-- |
|
$0.04M |
|
$3.02M |
|
$1.51M |
|
-- |
|
-- |
|
$1.51M |
|
$1.51M |
|
$1.51M |
|
$1.51M |
|
0.10M |
|
| Cash Flow Statement Financials | |
$-4.53M |
|
-- |
|
$1.06M |
|
$5.90M |
|
$2.43M |
|
$-3.47M |
|
$0.27M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.98 |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.53M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-368.84% |
|
-368.84% |
|
-184.45% |
|
-368.84% |
|
$15.73 |
|
$-70.51 |
|
$-70.51 |
|